Abstract
The pathogenesis and clinical significance of cerebral white matter lesions (WML) remain controversial. Various studies have shown that age, hypertension, diabetes mellitus and a history of stroke or heart disease are the most important factors related to cerebral WML. Other studies suggest that WML are closely related to the development of future strokes and other forms of cerebrovascular disease, such as cognitive impairment, in elderly patients with vascular risk factors, particularly hypertension. Angiotensin receptor blockers are antihypertensive drugs useful for the treatment of hypertension and cardiovascular diseases. Recent data from experimental studies and clinical trials suggest that they could be superior to other antihypertensive therapies in preventing the development of cerebrovascular disease and in reducing the risk of death and recurrences in patients with a previous stroke. This paper reviews the clinical importance of cerebral WML, their relationship with stroke development and data concerning cerebrovascular protection with angiotensin receptor blockers.
Keywords: Cerebral white matter lesions, stroke, angiotensin receptor blockers, hypertension, cerebrovascular disease
Current Drug Therapy
Title: Cerebral White Matter Lesions, Risk of Stroke and Cerebrovascular Protection with Angiotensin Receptor Blockers
Volume: 1 Issue: 1
Author(s): Alejandro d. l. Sierra and Cristina Sierra
Affiliation:
Keywords: Cerebral white matter lesions, stroke, angiotensin receptor blockers, hypertension, cerebrovascular disease
Abstract: The pathogenesis and clinical significance of cerebral white matter lesions (WML) remain controversial. Various studies have shown that age, hypertension, diabetes mellitus and a history of stroke or heart disease are the most important factors related to cerebral WML. Other studies suggest that WML are closely related to the development of future strokes and other forms of cerebrovascular disease, such as cognitive impairment, in elderly patients with vascular risk factors, particularly hypertension. Angiotensin receptor blockers are antihypertensive drugs useful for the treatment of hypertension and cardiovascular diseases. Recent data from experimental studies and clinical trials suggest that they could be superior to other antihypertensive therapies in preventing the development of cerebrovascular disease and in reducing the risk of death and recurrences in patients with a previous stroke. This paper reviews the clinical importance of cerebral WML, their relationship with stroke development and data concerning cerebrovascular protection with angiotensin receptor blockers.
Export Options
About this article
Cite this article as:
Sierra d. l. Alejandro and Sierra Cristina, Cerebral White Matter Lesions, Risk of Stroke and Cerebrovascular Protection with Angiotensin Receptor Blockers, Current Drug Therapy 2006; 1 (1) . https://dx.doi.org/10.2174/157488506775268452
DOI https://dx.doi.org/10.2174/157488506775268452 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Linezolid Induced Skin Reactions in a Multi Drug Resistant Infective Endocarditis Patient: A Rare Case
Current Drug Safety Curative Effects of <i>Dhatryadi ghrita</i> Bioactive Extracts on Ethanol Withdrawal Syndrome in Wistar Rats
Current Bioactive Compounds Dihydrobenzo[1,4]oxathiine: A Multi-Potent Pharmacophoric Heterocyclic Nucleus
Current Medicinal Chemistry Synthesis, Docking and Antidiabetic Activity of Some Newer Benzamide Derivatives as Potential Glucokinase Activators
Letters in Drug Design & Discovery Synthesis and Bioactivities of 2-Azetidinone Derivatives as Cholesterol Absorption Inhibitors
Medicinal Chemistry The Role of Berberine in the Multi-Target Treatment of Senile Dementia
Current Topics in Medicinal Chemistry Editorial [ Cardiovascular Risk Factor Modification: A sine qua non in the Management of Vascular Surgery Patients ]
Current Vascular Pharmacology Niacin: From Mechanisms of Action to Therapeutic Uses
Mini-Reviews in Medicinal Chemistry Management of Incidental Findings in the Era of Next-generation Sequencing
Current Genomics Psoriasis and Vascular Risk : An Update
Current Pharmaceutical Design The Developmental Origins of Osteoporosis
Current Genomics The Potential Roles of Gamma-Glutamyltransferase Activity in the Progression of Atherosclerosis and Cardiovascular Diseases
Vascular Disease Prevention (Discontinued) Heparin Oligosaccharides as Potential Therapeutic Agents in Senile Dementia
Current Pharmaceutical Design 10 Years of SELDI: What Have we Learnt?
Current Proteomics 1, 2-Benzisoxazole: A Privileged Structure with a Potential for Polypharmacology
Current Pharmaceutical Design Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors
Clinical Cancer Drugs Update on Glycoprotein IIb/IIIa: Role in Primary Coronary Intervention
Cardiovascular & Hematological Agents in Medicinal Chemistry From Diabetes to Metabolic Syndrome: A View Point on An Evolving Concept
Current Pharmaceutical Design Aortic Wave Velocity: A Noninvasive Method to Measure the Stiffness of Arteries and the Clinical Results of Supplements That Appear to Improve Arterial Stiffness
Current Aging Science Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure
Current Drug Targets